Advertisement
Advertisement
Cirok

Cirok Dosage/Direction for Use

ciprofloxacin

Manufacturer:

Ratnatris Pharma

Distributor:

One Pharma
Full Prescribing Info
Dosage/Direction for Use
Posology: The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the bodyweight.
The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course. Treatment of infections due to certain bacteria (e.g. Pseudomonas aeruginosa, Acinetobacter or Staphylococci) may require higher ciprofloxacin doses and co-administration with other appropriate antibacterial agents.
Treatment of some infections (e.g. pelvic inflammatory disease, intra-abdominal infections, infections in neutropenic patients and infections of bones and joints) may require co-administration with other appropriate antibacterial agents depending on the pathogens involved.
Adults: See Table 2.

Click on icon to see table/diagram/image

Paediatric population: See Table 3.

Click on icon to see table/diagram/image

Elderly Patients: Elderly patients should receive a dose selected according to the severity of the infection and the patient's creatinine clearance.
Renal and hepatic impairment: Recommended starting and maintenance doses for patients with impaired renal function: See Table 4.

Click on icon to see table/diagram/image

In patients with impaired liver function no dose adjustment is required.
Dosing in children with impaired renal and/or hepatic function has not been studied.
Method of administration: The tablets are to be swallowed unchewed with fluid. They can be taken independent of meal times. If taken on an empty stomach, the active substance is absorbed more rapidly. Ciprofloxacin tablets should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit-juice (e.g. calcium-fortified orange juice).
In severe cases or if the patient is unable to take tablets (e.g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement